Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06539949 · ClinicalTrials.gov registry record · NA

Efficacy of the Tony Robbins Rapid Planning Method (RPM)

A NA study of Anxiety and Stress, sponsored by Applied Science & Performance Institute.

Completed
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT06539949: Completed NA study of Anxiety and Stress, sponsored by Applied Science & Performance Institute.

NCT06539949 is a NA study of Anxiety and Stress that has completed, run by Applied Science & Performance Institute. The registered enrollment target is 140 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06539949, a NA study of Anxiety and Stress, has completed, sponsored by Applied Science & Performance Institute.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

This study will consist of an experimental group and a control group. Approximately 150 adult males and females from the ages of 19+ will take part in this study. Subjects will be divided into a Control and Experimental Group. Subjects for the control and experimental group will be recruited from our internal database of subjects who have previously shown interest in studies and from userinterviews. Subjects in the experimental group (RPM Group) will be admitted to the Tony Robbins Rapid Planning Method (RPM) virtually at no cost, while the subjects assigned to the control group, will not attend the event, but instead be required to regularly complete journaling involving a to-do-list of their weekly work tasks. Psychological assessment surveys will be taken before the event, and at 1 week (day 8-13), and 4 weeks (day 29-34) post intervention. The control group will take the psychological assessment before beginning journaling, and at 1 week (day 8-13), and 4 weeks (day 29-34) post intervention.

Primary Outcome

The PIL test is a 20-item self-report attitudinal scale designed to measure the extent to which a respondent perceives a general sense of meaning and purpose in life or respectively suffers from an "existential vacuum". This test is the first and the most-studied questionnaire to measure perceived life purpose and meaning. It consists of 11 items which focus on the respondents' mood (e.g., item 1: I am usually completely bored, neutral, exuberant, enthusiastic), 3 items which address life goals

Interventions

  • BEHAVIORAL Rapid Planning Method (RPM)
  • BEHAVIORAL Journaling

Study Locations (1)

Florida

  • The Applied Science and Performance Institute - Tampa

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2024-08-20
Est. Completion 2024-11-01
Phase NA

What the finished NCT06539949 record still lists

NCT06539949 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (68% lower).

The record links to 6 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Rapid Planning Method (RPM) is the first listed.

NCT06539949 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06539949 about?

NCT06539949 is a clinical study titled "Efficacy of the Tony Robbins Rapid Planning Method (RPM)". This study will consist of an experimental group and a control group. Approximately 150 adult males and females from the ages of 19+ will take part in this study. Subjects will be divided into a Control and Experimental Group. Subjects for the control and experimental group will be recruited from ou...

What is the current status of trial NCT06539949?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2024-08-20. Estimated completion is 2024-11-01.

What conditions does trial NCT06539949 study?

This clinical trial studies the following conditions: Anxiety, Stress, Mood, Well-Being, Psychological, Motivation.

What interventions are being tested in trial NCT06539949?

The interventions under investigation include: Rapid Planning Method (RPM) (BEHAVIORAL), Journaling (BEHAVIORAL).

Who is sponsoring clinical trial NCT06539949?

This trial is sponsored by Applied Science & Performance Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06539949 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06539949's enrollment target sits among peer trials

140 129th of 364 higher than 235 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06539949, the US trial registry maintained by the National Library of Medicine. NCT06539949 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.